Correlation Between Tempest Therapeutics and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Protagenic Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Protagenic Therapeutics.
Diversification Opportunities for Tempest Therapeutics and Protagenic Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Tempest and Protagenic is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Protagenic Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Protagenic Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 2.05 times less risky than Protagenic Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Protagenic Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 64.00 in Protagenic Therapeutics on August 30, 2024 and sell it today you would lose (4.20) from holding Protagenic Therapeutics or give up 6.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Protagenic Therapeutics
Performance |
| Timeline |
| Tempest Therapeutics |
| Protagenic Therapeutics |
Tempest Therapeutics and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Protagenic Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |